Skip to main content

Prenetics Global Ltd

corporate_fare Company Profile

Prenetics Global Ltd

PRE·NASDAQ·Life Sciences·CIK 0001876431

Prenetics Global Ltd is a consumer health company focused on advancing human health and longevity through science-backed products, global brand partnerships, and AI-driven operations. The company's business is organized around two brands: IM8 and CircleDNA. IM8, co-founded with David Beckham, is the flagship consumer health brand and generated $60.1 million in revenue in its first full fiscal year (FY2025), achieving $120 million in Annual Recurring Revenue (ARR) as of December 2025. IM8 ships to more than 30 countries and had a gross margin of approximately 63% in FY2025. This brand was developed to combine clinical-grade formulation with a consumer-grade brand experience. CircleDNA is a retained, complementary asset that generated $12.9 million in revenue in FY2025 with a gross margin of approximately 85%. In FY2025, Prenetics Global Ltd's total revenue from continuing operations was $92.4 million, with a gross profit of $48.8 million and a gross margin of 52.8%. The company reported a loss for the year of $(40.0) million and an Adjusted EBITDA Loss of $(13.9) million in FY2025. In Q4 2025, total revenue reached $36.6 million. IM8 operating metrics for Q4 2025 included monthly revenue of $10.0 million, quarterly revenue of $27.4 million, over 230,000 total customer orders, an average order value of $133, and a new customer subscription rate of approximately 80%.

Prenetics Global Ltd (NASDAQ:PRE) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 38 items for PRE at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Prenetics' IM8 Secures Jay Shetty as Global Ambassador and Shareholder
  • Prenetics Global Appoints Experienced CFO for Rapidly Expanding IM8 Subsidiary
  • Prenetics Global Raises IM8 Revenue Guidance, Reports Strong Q1 Growth & $19M Buyback
  • Prenetics Global Reports Q1 Revenue of $36M, Operating Loss of $8.9M
  • Prenetics' IM8 Secures Multi-Year Partnership with Inter Miami CF, Including Equity Stake

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$92.39M
Net Income
-$39.98M
Diluted EPS
-$2.68
Op. Cash Flow
-$21.83M
Free Cash Flow
-$22.03M
Gross Profit
$48.79M
Operating Income
-$44.48M
Cash & Equivalents
$32.13M
Debt / Equity
0.00×
Net Margin
-43.3%
Source: 20-F · filed 2026-04-30 · accession 0001628280-26-028623

Insider Transactions

PRE files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

$8.97 +1.93% today
52-week range · as of 2026-11-18 $8.97 – $27.24
Market cap
$149.05M
Volume
596.4K (2.3× avg)
3-mo avg 257.9K
Live data · 2026-11-22 03:33 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed PRE - Filings & News (Page 2)

PRE
May 20, 2026, 8:07 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $15.54
Real-time Price: $8.97 info
Change: -$6.57 (-42%) info
Market Cap: $149.052M info
PRE
May 14, 2026, 8:10 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $17.33
Real-time Price: $8.97 info
Change: -$8.36 (-48%) info
Market Cap: $149.052M info
PRE
May 14, 2026, 8:04 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $17.63
Real-time Price: $8.97 info
Change: -$8.66 (-49%) info
Market Cap: $149.052M info
PRE
May 14, 2026, 8:00 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $17.56
Real-time Price: $8.97 info
Change: -$8.59 (-49%) info
Market Cap: $149.052M info
PRE
May 07, 2026, 8:33 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $16.35
Real-time Price: $8.97 info
Change: -$7.38 (-45%) info
Market Cap: $149.052M info
PRE
May 04, 2026, 8:32 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $17.02
Real-time Price: $8.97 info
Change: -$8.05 (-47%) info
Market Cap: $149.052M info
PRE
Apr 30, 2026, 9:23 AM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $17.03
Real-time Price: $8.97 info
Change: -$8.06 (-47%) info
Market Cap: $149.052M info
PRE
Apr 02, 2026, 9:06 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $19.94
Real-time Price: $8.97 info
Change: -$10.97 (-55%) info
Market Cap: $149.052M info
PRE
Mar 31, 2026, 9:24 AM EDT
Filing Type: F-3
Importance Score:
7
Price at Filing: $19.95
Real-time Price: $8.97 info
Change: -$10.98 (-55%) info
Market Cap: $149.052M info
PRE
Mar 06, 2026, 8:07 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $15.05
Real-time Price: $8.97 info
Change: -$6.08 (-40%) info
Market Cap: $149.052M info
PRE
Mar 06, 2026, 8:07 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $15.05
Real-time Price: $8.97 info
Change: -$6.08 (-40%) info
Market Cap: $149.052M info
PRE
Mar 03, 2026, 8:47 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $15.97
Real-time Price: $8.97 info
Change: -$7.00 (-44%) info
Market Cap: $149.052M info
PRE
Mar 03, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $15.97
Real-time Price: $8.97 info
Change: -$7.00 (-44%) info
Market Cap: $149.052M info
PRE
Feb 18, 2026, 9:28 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $21.52
Real-time Price: $8.97 info
Change: -$12.55 (-58%) info
Market Cap: $149.052M info
PRE
Feb 17, 2026, 4:33 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $21.74
Real-time Price: $8.97 info
Change: -$12.77 (-59%) info
Market Cap: $149.052M info
PRE
Feb 17, 2026, 8:29 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $22.19
Real-time Price: $8.97 info
Change: -$13.22 (-60%) info
Market Cap: $149.052M info
PRE
Jan 06, 2026, 8:04 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $15.85
Real-time Price: $8.97 info
Change: -$6.88 (-43%) info
Market Cap: $149.052M info
PRE
Jan 05, 2026, 8:21 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $16.21
Real-time Price: $8.97 info
Change: -$7.24 (-45%) info
Market Cap: $149.052M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets